101 related articles for article (PubMed ID: 3365357)
1. Inhibition of HIV-1 replication by an antiviral xanthate compound in vitro.
Mellert W; Amtmann E; Erfle V; Sauer G
AIDS Res Hum Retroviruses; 1988 Feb; 4(1):71-81. PubMed ID: 3365357
[TBL] [Abstract][Full Text] [Related]
2. The antiviral xanthate compound D609 inhibits herpes simplex virus type 1 replication and protein phosphorylation.
Walro DG; Rosenthal KS
Antiviral Res; 1997 Sep; 36(1):63-72. PubMed ID: 9330762
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the phosphorylation of the regulatory non-structural protein of vesicular stomatitis virus by an antiviral xanthate compound.
Müller-Decker K; Amtmann E; Sauer G
J Gen Virol; 1987 Dec; 68 ( Pt 12)():3045-56. PubMed ID: 2447222
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of DNA synthesis in untransformed cells by the antiviral and antitumoral compound tricyclodecan-9-yl-xanthogenate (D609).
Kiss Z; Crilly KS; Chung T
Biochem Pharmacol; 1998 Mar; 55(6):915-8. PubMed ID: 9586966
[TBL] [Abstract][Full Text] [Related]
5. Tumor prevention by a xanthate compound in experimental mouse-skin tumorigenesis.
Fürstenberger G; Amtmann E; Marks F; Sauer G
Int J Cancer; 1989 Mar; 43(3):508-12. PubMed ID: 2494119
[TBL] [Abstract][Full Text] [Related]
6. Antiviral effects of xanthate D609 on the human respiratory syncytial virus growth cycle.
Villanueva N; Navarro J; Cubero E
Virology; 1991 Mar; 181(1):101-8. PubMed ID: 1994569
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antiviral effect of xanthates and ionic detergents.
Amtmann E; Müller-Decker K; Hoss A; Schalasta G; Doppler C; Sauer G
Biochem Pharmacol; 1987 May; 36(9):1545-9. PubMed ID: 3034292
[TBL] [Abstract][Full Text] [Related]
8. DNA and RNA virus species are inhibited by xanthates, a class of antiviral compounds with unique properties.
Sauer G; Amtmann E; Melber K; Knapp A; Müller K; Hummel K; Scherm A
Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3263-7. PubMed ID: 6328507
[TBL] [Abstract][Full Text] [Related]
9. Selective killing of tumor cells by xanthates.
Amtmann E; Sauer G
Cancer Lett; 1987 Jun; 35(3):237-44. PubMed ID: 3594421
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic aspects of the synergistic antiviral effect of xanthates and monocarbonic acids.
Music L; Müller-Decker K; Amtmann E; Sauer G
Biochem Pharmacol; 1989 Jun; 38(12):1941-5. PubMed ID: 2545206
[TBL] [Abstract][Full Text] [Related]
11. Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound: inhibition of a phospholipase C-type reaction.
Müller-Decker K
Biochem Biophys Res Commun; 1989 Jul; 162(1):198-205. PubMed ID: 2751648
[TBL] [Abstract][Full Text] [Related]
12. The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C.
Amtmann E
Drugs Exp Clin Res; 1996; 22(6):287-94. PubMed ID: 9034754
[TBL] [Abstract][Full Text] [Related]
13. Antiviral xanthate causes conformational changes in simian virus 40 DNA and chromatin.
Waldeck W
Oncology; 1990; 47(2):191-8. PubMed ID: 2156205
[TBL] [Abstract][Full Text] [Related]
14. Interruption of growth signal transduction by an antiviral and antitumoral xanthate compound.
Müller-Decker K; Doppler C; Amtmann E; Sauer G
Exp Cell Res; 1988 Aug; 177(2):295-302. PubMed ID: 2839351
[TBL] [Abstract][Full Text] [Related]
15. D609 inhibits ionizing radiation-induced oxidative damage by acting as a potent antioxidant.
Zhou D; Lauderback CM; Yu T; Brown SA; Butterfield DA; Thompson JS
J Pharmacol Exp Ther; 2001 Jul; 298(1):103-9. PubMed ID: 11408530
[TBL] [Abstract][Full Text] [Related]
16. Tricyclodecan-9-yl-Xanthogenate (D609): Mechanism of Action and Pharmacological Applications.
Bhat AH; Dar KB; Khan A; Alshahrani S; Alshehri SM; Ghoneim MM; Alam P; Shakeel F
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328726
[TBL] [Abstract][Full Text] [Related]
17. Anti-proliferative effects of tricyclodecan-9-yl-xanthogenate (D609) involve ceramide and cell cycle inhibition.
Gusain A; Hatcher JF; Adibhatla RM; Wesley UV; Dempsey RJ
Mol Neurobiol; 2012 Jun; 45(3):455-64. PubMed ID: 22415444
[TBL] [Abstract][Full Text] [Related]
18. Basement membrane biosynthesis as a target to tumor therapy.
Maragoudakis ME; Missirlis E; Sarmonika M; Panoutsacopoulou M; Karakiulakis G
J Pharmacol Exp Ther; 1990 Feb; 252(2):753-7. PubMed ID: 1690295
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric evaluation of anti-herpes drugs.
Rosenthal KS; Hodnichak CM; Summers JL
Cytometry; 1987 Jul; 8(4):392-5. PubMed ID: 3040355
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of basement membrane collagen synthesis prevent endothelial cell alignment in matrigel in vitro and angiogenesis in vivo.
Haralabopoulos GC; Grant DS; Kleinman HK; Lelkes PI; Papaioannou SP; Maragoudakis ME
Lab Invest; 1994 Oct; 71(4):575-82. PubMed ID: 7526036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
